Afridi, S., Sharma, P., Choudhary, F., Rizwan, A., Nizam, A., Parvez, A., & Farooqi, H. (2024). Extracellular vesicles: A new approach to study the brain’s neural system and its diseases. Cell Biochemistry and Biophysics, 82(2), 521–534. https://doi.org/10.1007/s12013-024-01271-3

Article  CAS  PubMed  Google Scholar 

Agibalova, T., Hempel, A., Maurer, H. C., Ragab, M., Ermolova, A., Wieland, J., Waldherr, C., Heindl, F., Giller, M., Fischer, J. C., Tschurtschenthaler, M., Kohnke-Ertel, B., Öllinger, R., Steiger, K., Demir, I. E., Saur, D., Quante, M., Schmid, R. M., & Middelhoff, M. (2024). Vasoactive intestinal peptide promotes secretory differentiation and mitigates radiation-induced intestinal injury. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-024-03958-z

Article  Google Scholar 

Arrieta, V. A., Gould, A., Kim, K.-S., Habashy, K. J., Dmello, C., Vázquez-Cervantes, G. I., Palacín-Aliana, I., McManus, G., Amidei, C., Gomez, C., Dhiantravan, S., Chen, L., Zhang, D. Y., Saganty, R., Cholak, M. E., Pandey, S., McCord, M., McCortney, K., Castro, B., & Ward, R. (2024). Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas. Nature Communications, 15(1), 4698. https://doi.org/10.1038/s41467-024-48326-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aslam, E., Gijasi, A., Perner, C., Wijk, R. V., & Mashaghi, A. (2024). Immunobiology and pharmacology of neuropeptide substance P. Elsevier.

Google Scholar 

Ayala-Sarmiento, A. E., Martinez-Fong, D., & Segovia, J. (2015). The internalization of neurotensin by the low-affinity neurotensin receptors (NTSR2 and vNTSR2) activates ERK 1/2 in glioma cells and allows neurotensin-polyplex transfection of tGAS1. Cellular and Molecular Neurobiology, 35(6), 785–795. https://doi.org/10.1007/s10571-015-0172-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bagley, S. J., Kothari, S., Rahman, R., Lee, E. Q., Dunn, G. P., Galanis, E., Chang, S. M., Nabors, L. B., Ahluwalia, M. S., Stupp, R., Mehta, M. P., Reardon, D. A., Grossman, S. A., Sulman, E. P., Sampson, J. H., Khagi, S., Weller, M., Cloughesy, T. F., Wen, P. Y., & Khasraw, M. (2021). Glioblastoma clinical trials: Current landscape and opportunities for improvement. Clinical Cancer Research, 28(4), 594–602. https://doi.org/10.1158/1078-0432.ccr-21-2750

Article  Google Scholar 

Bensalma, S., Turpault, S., Balandre, A.-C., De Boisvilliers, M., Gaillard, A., Chadéneau, C., & Muller, J.-M. (2019). PKA at a cross-road of signaling pathways involved in the regulation of glioblastoma migration and invasion by the neuropeptides VIP and PACAP. Cancers, 11(1), 123–123. https://doi.org/10.3390/cancers11010123

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boudouresque, F., Berthois, Y., Martin, P.-M., Figarella-Branger, D., Chinot, O., & Ouafik, L. (2005). Role of adrenomedullin in glioblastomas growth. Bulletin Du Cancer, 92(4), 317–326.

CAS  PubMed  Google Scholar 

Cáceda, R., Kinkead, B., & Nemeroff, C. B. (2006). Neurotensin: Role in psychiatric and neurological diseases. Peptides, 27(10), 2385–2404. https://doi.org/10.1016/j.peptides.2006.04.024

Article  CAS  PubMed  Google Scholar 

Cai, R., Zhang, X., Wang, H., Cui, T., Halmos, G., Sha, W., He, J., Popovics, P., Vidaurre, I., Zhang, C., Mirsaeidi, M., & Schally, A. V. (2022). Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity. Peptides, 150, 170716. https://doi.org/10.1016/j.peptides.2021.170716

Article  CAS  PubMed  Google Scholar 

Chuang, C.-C., Lan, Y.-H., Lu, Y.-J., Weng, Y.-L., & Chen, J.-P. (2022). Targeted delivery of irinotecan and SLP2 shRNA with GRP-conjugated magnetic graphene oxide for glioblastoma treatment. Biomaterials Science, 10(12), 3201–3222. https://doi.org/10.1039/d2bm00420h

Article  CAS  PubMed  Google Scholar 

Conroy, S., Wagemakers, M., Walenkamp, A. M. E., Kruyt, F. A. E., & den Dunnen, W. F. A. (2016). Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses. Journal of Neuro-Oncology, 131(1), 11–20. https://doi.org/10.1007/s11060-016-2269-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dahan, M., Zohar, J., Doron, T., Mathé, A. A., & Cohen, H. (2024). Exploring the anxiolytic potential of NPY by a dipeptidyl peptidase-IV inhibitor in an animal model of PTSD. The International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyae062

Article  PubMed  PubMed Central  Google Scholar 

Eipper, B. A., Stoffers, D. A., & Mains, R. E. (1992). The biosynthesis of neuropeptides: Peptide alpha-amidation. Annual Review of Neuroscience, 15(1), 57–85. https://doi.org/10.1146/annurev.ne.15.030192.000421

Article  CAS  PubMed  Google Scholar 

Fernandez-Sauze, S., Delfino, C., Mabrouk, K., Dussert, C., Chinot, O., Martin, P., Grisoli, F., Ouafik, L., & Boudouresque, F. (2004). Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: Involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors. International Journal of Cancer, 108(6), 797–804. https://doi.org/10.1002/ijc.11663

Article  CAS  PubMed  Google Scholar 

Fortin, S. P., Ennis, M. J., Schumacher, C. A., Zylstra-Diegel, C. R., Williams, B. O., Ross, J. T. D., Winkles, J. A., Loftus, J. C., Symons, M. H., & Tran, N. L. (2012). Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells. Molecular Cancer Research : MCR, 10(7), 958–968. https://doi.org/10.1158/1541-7786.MCR-11-0616

Article  CAS  PubMed  Google Scholar 

Fuentes-Fayos, A. C., García, M. E., Pérez-Gómez, J. M., Peel, A., Blanco-Acevedo, C., Solivera, J., Ibáñez-Costa, A., Gahete, M. D., Castaño, J. P., & Luque, R. M. (2022). Somatostatin receptor splicing variant sst5TMD4 overexpression in glioblastoma is associated with poor survival, increased aggressiveness features, and somatostatin analogs resistance. International Journal of Molecular Sciences, 23(3), 1143. https://doi.org/10.3390/ijms23031143

Article  CAS  PubMed  PubMed Central  Google Scholar 

González-Mora, A. M., & Garcia-Lopez, P. (2021). Estrogen receptors as molecular targets of endocrine therapy for glioblastoma. International Journal of Molecular Sciences, 22(22), 12404. https://doi.org/10.3390/ijms222212404

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grouzmann, E., Meyer, C., Bürki, E., & Brunner, H. (2001). Neuropeptide Y Y2 receptor signaling mechanisms in the human glioblastoma cell line LN319. Peptides, 22(3), 379–386. https://doi.org/10.1016/s0196-9781(01)00344-8

Article  CAS  PubMed  Google Scholar 

Halik, P. K., Koźmiński, P., Matalińska, J., Lipiński, P. F. J., Misicka, A., & Gniazdowska, E. (2022). In vitro biological evaluation of aprepitant based 177Lu-radioconjugates. Pharmaceutics, 14(3), 607. https://doi.org/10.3390/pharmaceutics14030607

Article  CAS  PubMed  PubMed Central  Google Scholar 

Halik, P. K., Lipiński, P. F. J., Matalińska, J., Koźmiński, P., Misicka, A., & Gniazdowska, E. (2020). Radiochemical synthesis and evaluation of novel radioconjugates of neurokinin 1 receptor antagonist aprepitant dedicated for NK1R-positive tumors. Molecules (Basel, Switzerland), 25(16), 3756. https://doi.org/10.3390/molecules25163756

Article  CAS  PubMed  Google Scholar 

Huan, R., Zhang, J., Yue, J., Yang, S., Han, G., Cheng, Y., & Tan, Y. (2024). Orexin-A mediates glioblastoma proliferation inhibition by increasing ferroptosis triggered by unstable iron pools and GPX4 depletion. Journal of Cellular and Molecular Medicine, 28(9), e18318. https://doi.org/10.1111/jcmm.18318

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang, C. S., Chang, Y.-H., Lee, H.-H., Wu, J., Huang, J.-Y., Chung, Y., Hsu, S.-T., Chow, L.-P., Wei, K.-C., & Huang, F. (2020). Irisin, an exercise myokine, potently suppresses tumor proliferation, invasion, and growth in glioma. The FASEB Journal, 34(7), 9678–9693. https://doi.org/10.1096/fj.202000573rr

Article  CAS  PubMed  Google Scholar 

Huang, Q., Chen, L., Liang, J., Huang, Q., & Sun, H. (2022). Neurotransmitters: Potential targets in glioblastoma. Cancers, 14(16), 3970. https://doi.org/10.3390/cancers14163970

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jaszberenyi, M., Schally, A. V., Block, N. L., Zarandi, M., Cai, R.-Z., Vidaurre, I., Szalontay, L., Jayakumar, A. R., & Rick, F. G. (2013). Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro. Targeted Oncology, 8(4), 281–290. https://doi.org/10.1007/s11523-013-0264-y

Article  PubMed  Google Scholar 

Jégou, S., Javoy-Agid, F., Delbende, C., Tranchand-Bunel, D., Coy, D. H., Agid, Y., & Vaudry, H. (2003). Regional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects. Peptides, 9(4), 787–793. https://doi.org/10.1016/0196-9781(88)90123-4

Article